EU Urban Wastewater Directive ‘Highly Disproportionate,’ Says AESGP

Pharmaceutical industry associations are united in their view that the revised EU Urban Wastewater Treatment Directive discriminates against medicines and cosmetics producers.

Wastewater tank
EU pharmaceutical and cosmetic manufacturers must pay at least 80% of quaternary treatment costs according to UWWTD (Shutterstock)

The Association of the European Self-Care Industry, AESGP, has criticized European Union regulators for singling out the pharmaceutical and cosmetics sectors to pay for pollutant removal as part of the Urban Wastewater Treatment Directive.

“Doing our best to protect the environment is a societal obligation for which we are all responsible,” commented AESGP director general Jurate Švarcaite. “It seems to us, however, highly disproportionate...

More from Europe

More from ESG